|Values are valid only on day of printing.|
Updated: June 2013
The National Institute of Health (NIH) has reported that as many as 1% (3,000,000) of all Americans have celiac disease and hundreds of thousands of these patients are undiagnosed. In 2006, the NIH launched an aggressive campaign to heighten physician awareness of the disease. With new diagnostic guidelines and new tests available, this effort should significantly reduce the time to diagnosis, which currently averages 10 years from the onset of symptoms.
Laboratory algorithms using a reflex approach provide an alternative to ordering individual tests when evaluating a patient with suspected celiac disease. The goal of algorithms is to provide the most appropriate selection of tests for each patient, while maintaining the highest possible sensitivity and specificity.
To help you order the right test at the right time and reduce unnecessary testing, Mayo Medical Laboratories has developed 3 new celiac test algorithms:
With the new testing options offered by Mayo Medical Laboratories, physicians can now utilize simple, algorithmic approaches to evaluate patients at risk for celiac disease and to monitor treatment, improving the lives of these patients.